Effects of coverage extent and slice skipping on mean and maximum arterial 18F-FDG uptake ratios in patients with carotid plaque

Annals of Nuclear Medicine

Volumn 26, Issue 9, 2012, Pages 715-722

  Noh, Tae Soo ^a   Yoo, Jang ^a   Kim, Se Won ^b   Lee, Eun Jeong ^a   Choi, Joon Young ^a   Kim, Byung Tae ^a   Lee, Kyung Han ^a  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

18F FDG; Atherosclerosis; Carotid artery; PET CT; Uptake ratio

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTERY INTIMA; ARTICLE; ASCENDING AORTA; BODY MASS; CARDIOMETABOLIC RISK; CAROTID ARTERY; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; COMMON CAROTID ARTERY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DRUG UPTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ACCURACY; PRIORITY JOURNAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; CAROTID ARTERIES; CAROTID STENOSIS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; SIGNAL-TO-NOISE RATIO;

EID: 84872116445     PISSN: 09147187     EISSN: 18646433     Source Type: Journal    
DOI: 10.1007/s12149-012-0633-0     Document Type: Article

References (25)

1. Nichols WW, Pepine CJ, O'Rourke MF. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke. N Engl J Med. 1999;340:1762-3. (Pubitemid 29252609)
2. Rothwell PM. Carotid artery disease and the risk of ischaemic stroke and coronary vascular events. Cerebrovasc Dis. 2000;10: 21-33.
3. U-King-Im JM, Young V, Gillard JH. Carotid-artery imaging in the diagnosis and management of patients at risk of stroke. Lancet Neurol. 2009;8:569-80.
4. Rudd JH, Narula J, Strauss HW, Virmani R, Machac J, Klimas M, et al. Imaging atherosclerotic plaque inflammation by fluorodeoxyglucose with positron emission tomography: ready for prime time? J Am Coll Cardiol. 2010;55:2527-35.
5. Rudd JH, Myers KS, Bansilal S, Machac J, Woodward M, Fuster V, et al. Relationships among regional arterial inflammation, calcification, risk factors, and biomarkers: a prospective fluorodeoxyglucose positron-emission tomography/computed tomography imaging study. Circ Cardiovasc Imaging. 2009;2:107-15.
6. Kim TN, Kim S, Yang SJ, Yoo HJ, Seo JA, Kim SG, et al. Vascular inflammation in patients with impaired glucose tolerance and type 2 diabetes: analysis with 18F-fluorodeoxyglucose positron emission tomography. Circ Cardiovasc Imaging. 2010;3: 142-8.
7. Bucerius J, Duivenvoorden R, Mani V, Moncrieff C, Rudd JH, Calcagno C, et al. Prevalence and risk factors of carotid vessel wall inflammation in coronary artery disease patients: fDG-PET and CT imaging study. JACC Cardiovasc Imaging. 2011;4: 1195-205.
8. Lee SJ, On YK, Lee EJ, Choi JY, Kim BT, Lee KH. Reversal of vascular 18F-FDG uptake with plasma high-density lipoprotein elevation by atherogenic risk reduction. J Nucl Med. 2008;49: 1277-82.
9. Tahara N, Kai H, Ishibashi M, Nakaura H, Kaida H, Baba K, et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol. 2006;48:1825-31.
10. Mizoguchi M, Tahara N, Tahara A, Nitta Y, Kodama N, Oba T, et al. Pioglitazone attenuates atherosclerotic plaque inflammation in patients with impaired glucose tolerance or diabetes a prospective, randomized, comparator-controlled study using serial 18F-FDG PET/CT imaging study of carotid artery and ascending aorta. JACC Cardiovasc Imaging. 2011;4:1110-8.
11. Paulmier B, Duet M, Khayat R, Pierquet-Ghazzar N, Laissy JP, Maunoury C, et al. Arterial wall uptake of fluorodeoxyglucose onPET imaging in stable cancer disease patients indicates higher risk for cardiovascular events. J Nucl Cardiol. 2008;15:209-17.
12. Rominger A, Saam T, Wolpers S, Cyran CC, Schmidt M, Foerster S, et al. 18F-FDG PET/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med. 2009;50:1611-20.
13. Rudd JH, Myers KS, Bansilal S, Machac J, Rafique A, Farkouh M, et al. 18F-Fluorodeoxyglucose positron emission tomography imaging of atherosclerotic plaque inflammation is highly reproducible: implications for atherosclerosis therapy trials. J Am Coll Cardiol. 2007;50:892-6. (Pubitemid 47268746)
14. Rudd JH, Myers KS, Bansilal S, Machac J, Pinto CA, Tong C, et al. Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations. J Nucl Med. 2008;49:871-8. (Pubitemid 351793426)
15. Hiari N, Rudd JHF. FDG PET Imaging and Cardiovascular Inflammation. Curr Cardiol Rep. 2011;13:43-8.
16. Bucerius J, Mani V, Moncrieff C, Rudd JH, Machac J, Fuster V, et al. Impact of noninsulin-dependent type 2 diabetes on carotid wall 18F-fluorodeoxyglucose positron emission tomography uptake. J Am Coll Cardiol. 2012;59:2080-8.
17. Tahara N, Kai H, Yamagishi S, Mizoguchi M, Nakaura H, Ishibashi M, et al. Vascular inflammation evaluated by [18F]-fluorodeoxyglucose positron emission tomography is associated with the metabolic syndrome. J Am Coll Cardiol. 2007;49:1533-9. (Pubitemid 46517964)
18. Silvera SS, Aidi HE, Rudd JH, Mani V, Yang L, Farkouh M, et al. Multimodality imaging of atherosclerotic plaque activity and composition using FDG-PET/CT and MRI in carotid and femoral arteries. Atherosclerosis. 2009;207:139-43.
19. Fayad ZA, Mani V, Woodward M, Kallend D, Abt M, Burgess T, et al. dal-PLAQUE Investigators. Safety and efficacy of dalcetrapib on atherosclerotic disease using novel non-invasive multimodality imaging (dal-PLAQUE): a randomised clinical trial. Lancet. 2011;378:1547-59.
20. Jaff MR. Imaging the carotid bifurcation: toward standardization. Semin Vasc Surg. 2008;21:73-9. (Pubitemid 351815175)
21. Arora S, Chien JD, Cheng SC, Chun KA, Wintermark M. Optimal carotid artery coverage for carotid plaque CT-imaging in predicting ischemic stroke. J Neuroradiol. 2010;37:98-103.
22. Bural GG, Torigian DA, Chamroonrat W, Houseni M, Chen W, Basu S, et al. FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries. Eur J Nucl Med Mol Imaging. 2008;35:562-9. (Pubitemid 351674338)
23. Yang SJ, Kim S, Hwang SY, Kim TN, Choi HY, Yoo HJ, et al. Association between sRAGE, esRAGE levels and vascular inflammation: analysis with 18F-fluorodeoxyglucose positron emission tomography. Atherosclerosis. 2012;220:402-6.
24. Yoo HJ, Kim S, Park MS, Yang SJ, Kim TN, Seo JA, et al. Vascular inflammation stratified by C-reactive protein and lowdensity lipoprotein cholesterol levels: analysis with 18F-FDG PET. J Nucl Med. 2011;52:10-7.
25. Potter K, Lenzo N, Eikelboom JW, Arnolda LF, Beer C, Hankey GJ. Effect of long-term homocysteine reduction with b vitamins on arterial wall inflammation assessed by fluorodeoxyglucose positron emission tomography. Cerebrovasc Dis. 2009;27: 259-65.